Cortexyme Inc. (CRTX) PT Doubles to $150 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Sumant Kulkarni raised the price target on Cortexyme Inc. (NASDAQ: CRTX) to $150.00 (from $75.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE